Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020

By H. Qiu, S. Cao, Ruihua Xu. Cancer Communications, 2021

845 citations recorded by the source corpus.

Cancer is one of the leading causes of death and a main economic burden in China. Investigating the differences in cancer patterns and control strategies between China and developed countries could provide reference for policy planning and contribute to improving cancer control measures. In this study, we reviewed the rates and trends of cancer incidence and mortality and disability‐adjusted life year (DALY) burden in China, and compared them with those in the United States (US) and the United Kingdom (UK).

Subfields: Economics and Econometrics, Oncology

View Paper: https://www.semanticscholar.org/paper/b666ceea994d1f11508f3ef006d697e2da7815a9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Ruifeng Xu
2. Ye-Mei He
3. Wen-long Guan

Citations in the corpus

• Gastric cancer treatment: recent progress and future perspectives (2023, background): “Despite the high incidence of GC, most patients are unfortunately diagnosed at advanced stages with dismal prognoses due to the lack of distinguishing clinical indications [7, 8].”